newsfilter
← Latest News
GlobeNewswire·

Icosavax to Participate in the William Blair Biotech Focus Conference

SEATTLE, July 06, 2022 (GLOBE NEWSWIRE) -- Icosavax, Inc. (NASDAQ:ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial focus on life-